These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 30103916)

  • 1. Circannual variability in adrenocorticotropic hormone responses to administration of thyrotropin-releasing hormone in clinically normal horses in Australia.
    Byrne DP; Secombe CJ; Tan RHH; Perera DI; Watts SP; Wearn JG
    Vet J; 2018 Aug; 238():58-62. PubMed ID: 30103916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of seasonal influences on adrenocorticotropic hormone response to the thyrotropin-releasing hormone stimulation test and its accuracy for diagnosis of pituitary pars intermedia dysfunction.
    Adams AA; Siard-Altman MH; Reedy SE; Barker D; Elzinga S; Sanz MG; Urschel K; Ireland JL
    Vet J; 2023; 300-302():106035. PubMed ID: 37802466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenocorticotropin concentration following administration of thyrotropin-releasing hormone in healthy horses and those with pituitary pars intermedia dysfunction and pituitary gland hyperplasia.
    Beech J; Boston R; Lindborg S; Russell GE
    J Am Vet Med Assoc; 2007 Aug; 231(3):417-26. PubMed ID: 17669045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of cortisol and ACTH responses after administration of thyrotropin releasing hormone in normal horses and those with pituitary pars intermedia dysfunction.
    Beech J; Boston R; Lindborg S
    J Vet Intern Med; 2011; 25(6):1431-8. PubMed ID: 22092639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-melanocyte stimulating hormone release in response to thyrotropin releasing hormone in healthy horses, horses with pituitary pars intermedia dysfunction and equine pars intermedia explants.
    McFarlane D; Beech J; Cribb A
    Domest Anim Endocrinol; 2006 May; 30(4):276-88. PubMed ID: 16115743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of freeze-thaw cycles on determination of immunoreactive plasma adrenocorticotrophic hormone concentrations in horses.
    Hu K; Stewart AJ; Yuen KY; Hinrichsen S; Dryburgh EL; Bertin FR
    J Vet Intern Med; 2020 May; 34(3):1350-1356. PubMed ID: 32255541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BEVA primary care clinical guidelines: Diagnosis and management of equine pituitary pars intermedia dysfunction.
    Menzies-Gow NJ; Banse HE; Duff A; Hart N; Ireland JL; Knowles EJ; McFarlane D; Rendle D
    Equine Vet J; 2024 Mar; 56(2):220-242. PubMed ID: 37795557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of combined testing to simultaneously diagnose pituitary pars intermedia dysfunction and insulin dysregulation in horses.
    Horn R; Bertin FR
    J Vet Intern Med; 2019 Sep; 33(5):2249-2256. PubMed ID: 31498947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seasonal changes in plasma adrenocorticotropic hormone and α-melanocyte-stimulating hormone in response to thyrotropin-releasing hormone in normal, aged horses.
    Funk RA; Stewart AJ; Wooldridge AA; Kwessi E; Kemppainen RJ; Behrend EN; Zhong Q; Johnson AK
    J Vet Intern Med; 2011; 25(3):579-85. PubMed ID: 21457320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of imprecise sampling time for 10- and 30-min thyrotropin-releasing hormone stimulation tests in horses.
    Vorster DM; Wang W; Kemp KL; Bamford NJ; Bertin FR
    Equine Vet J; 2024 Mar; 56(2):291-298. PubMed ID: 37649416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeatability of a thyrotropin-releasing hormone stimulation test for diagnosis of pituitary pars intermedia dysfunction in mature horses.
    Kam YN; McKenzie K; Coyle M; Bertin FR
    J Vet Intern Med; 2021 Nov; 35(6):2885-2890. PubMed ID: 34642962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. α-Melanocyte--stimulating hormone and adrenocorticotropin concentrations in response to thyrotropin-releasing hormone and comparison with adrenocorticotropin concentration after domperidone administration in healthy horses and horses with pituitary pars intermedia dysfunction.
    Beech J; McFarlane D; Lindborg S; Sojka JE; Boston RC
    J Am Vet Med Assoc; 2011 May; 238(10):1305-15. PubMed ID: 21568777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implications of using adrenocorticotropic hormone diagnostic cutoffs or reference intervals to diagnose pituitary pars intermedia dysfunction in mature horses.
    Horn R; Stewart AJ; Jackson KV; Dryburgh EL; Medina-Torres CE; Bertin FR
    J Vet Intern Med; 2021 Jan; 35(1):560-570. PubMed ID: 33368633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of feeding status, time of the day, and season on baseline adrenocorticotropic hormone and the response to thyrotropin releasing hormone-stimulation test in healthy horses.
    Diez de Castro E; Lopez I; Cortes B; Pineda C; Garfia B; Aguilera-Tejero E
    Domest Anim Endocrinol; 2014 Jul; 48():77-83. PubMed ID: 24906932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circannual variation in plasma adrenocorticotropic hormone concentrations in the UK in normal horses and ponies, and those with pituitary pars intermedia dysfunction.
    Copas VE; Durham AE
    Equine Vet J; 2012 Jul; 44(4):440-3. PubMed ID: 21848531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of pergolide mesylate on adrenocorticotrophic hormone responses to exogenous thyrotropin releasing hormone in horses.
    Durham AE
    Vet J; 2022 Jul; 285():105831. PubMed ID: 35477010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a thyrotropin-releasing hormone solution stored at room temperature for pituitary pars intermedia dysfunction testing in horses.
    Goodale L; Frank N; Hermida P; D'Oench S
    Am J Vet Res; 2015 May; 76(5):437-44. PubMed ID: 25909376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of equine pituitary pars intermedia dysfunction.
    Stewart AJ; Ireland JL; Durham AE; McGowan CM
    Vet J; 2023; 300-302():106036. PubMed ID: 37805159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of adrenocorticotrophic hormone as a potential biomarker of pituitary pars intermedia dysfunction in horses.
    Lee ZY; Zylstra R; Haritou SJ
    Vet J; 2010 Jul; 185(1):58-61. PubMed ID: 20537574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of withholding feed on thyrotropin-releasing hormone stimulation test results and effects of combined testing on oral sugar test and thyrotropin-releasing hormone stimulation test results in horses.
    Restifo MM; Frank N; Hermida P; Sanchez-Londoño A
    Am J Vet Res; 2016 Jul; 77(7):738-48. PubMed ID: 27347827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.